HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
View All | Scroll Down Scroll Up
Quote:
Login Free Membership
Search:

Tale of the Tape  

Bearish MACD for INFI

Share
August 16, 2011 | Comment(s): 0
Recommended this article (6)
INFI
Infinity Pharmaceuticals Inc.’s (INFI - Snapshot Report) MACD indicator has entered into bearish territory with a reading of -0.2649. The Zacks #4 Rank (“Sell”) stock decreased more than 2% to $7.24 in morning trade. The Zacks Consensus Estimate for the year ending December 2011 has worsened by 5 cents over the past week to a loss of $1.36 per share.

 

Read the full analyst report on INFI

 

Please login to Zacks.com or register to post a comment.
Disclosure / Disclaimer Link


Email
Print
Share
Rate Pos
Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

More Zacks Links

Market Summary May 26, 2012 13:50 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center

Top Zacks Features

Free Membership
Zacks Rank
Equity Research
Portfolio Tracker
Screening
Premium Screens
Mutual Funds
Options
Zacks Video
Education
RSS Feed
Profit from the Pros

Subscription Services

Product Guide
Method for Trading
Chart Patterns
FTM Trader
Home Run Investor
Income Plus
Insider Trader
Options Trader
Reitmeister Alert
Tactical Trader
Top 10 Stocks
Turnaround Trader
Whisper Trader
Research Wizard
People & Picks
Zacks Premium
Zacks Ultimate
Zacks.com: About Zacks | Education | Advertise | Affiliate | Media | Careers | Contact Us | Services | Help | Disclaimer | Privacy Policy | Sitemap

Copyright 2011 Zacks Investment Research

Zacks Investment Research is one of the most highly regarded firms in the investment industry. The guiding principle behind our work is that there must be a good reason for brokerage firms to spend billions of dollars a year on stock research. Obviously, these investment experts know something special that may be indicative of the future direction of stock prices. From day one, we were determined to unlock that secret knowledge and make it available to our clients to help them improve their investment results.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.